Aadivighnesh Chem Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-06-2024
- Paid Up Capital ₹ 0.10 M
as on 15-06-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 15-06-2024
- Revenue 56.50%
(FY 2023)
- Profit 125.63%
(FY 2023)
- Ebitda 153.05%
(FY 2023)
- Net Worth 20.45%
(FY 2023)
- Total Assets 28.38%
(FY 2023)
About Aadivighnesh Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Devang Shah, Indira Shah, Amish Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397MH2004PTC147379
- Company No.
147379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aadivighnesh Chem Private Limited offer?
Aadivighnesh Chem Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Aadivighnesh Chem?
Board Members(4)
Financial Performance and Corporate Structure Insights of Aadivighnesh Chem.
Aadivighnesh Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.5% increase. The company also saw a substantial improvement in profitability, with a 125.63% increase in profit. The company's net worth Soared by an impressive increase of 20.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aadivighnesh Chem?
In 2023, Aadivighnesh Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ahepra Healthcare Private Limited
Active
29 years 8 months Devang Shah and Amish Shah are mutual person
Innovative Speciality Ingredients Private Limited
Active 11 years 3 months Devang Shah and Amish Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Jain Sahakari Bank Ltd Creation Date: 31 Oct 2013 | ₹5.00 M | Open |
How Many Employees Work at Aadivighnesh Chem?
Unlock and access historical data on people associated with Aadivighnesh Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aadivighnesh Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aadivighnesh Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
